11% increase in sales with more than $100,000 Net Profit
Symbol: CXG.A-CDNX
www.clemex.com
Shares Outstanding: 30,999,810
MONTREAL,
Dec. 14, 2012 /CNW Telbec/ - Clemex
Technologies Inc. (TSXV: CXG.A), designer and manufacturer of Image
Analysis systems and software for microscopy applications,
announces its financial results for the second Quarter of FY2013
ending October 31st, 2012.
For this second Quarter, sales reached $1,570,451 an increase of 11% compared to the
same period last year. The Corporation ends this quarter with a Net
Profit of $101,047 compared to a Net
Profit of $12,004 posted last year.
As for the first six month period of FY2013, sales reached
$2,875,603 compared to $2,655,142 last year while the Company posted a
Net Profit of $56,782 compared to a
Net Loss of $34,243 for the same
period last year.
During this past Quarter, the Corporation made
several sales to clients in the manufacturing sector in
North America: Teutech Industries,
Ontario, Canada, Nitrex Metal,
Quebec, Canada, Total
Petrochemicals, Texas (USA),
Gerdau, Arkansas (USA), Steel
Dynamics, IN (USA) and Raytheon Company, Texas (USA). As for the International
side, the Corporation made substantial sales to General Motors,
Mexico, NRB Bearings India and to
Hyundai Motors, South Korea.
FINANCIAL
HIGHLIGHTS
|
Quarter |
Semester |
Fiscal Years |
2013 |
2012 |
2013 |
2012 |
|
$ |
$ |
$ |
$
|
Sales |
1,570,451 |
1,414,314 |
2,875,603 |
2,655,142 |
|
|
|
|
|
Gross Margin |
877,067 |
761,339 |
1,541,933 |
1,429,510 |
Gross Margin % |
55.8% |
53.8% |
53.6% |
53.8% |
Total Operating Expenses |
728,520 |
712,335 |
1,412,151 |
1,398,753 |
|
|
|
|
|
Income Taxes |
47,500 |
37,000 |
73,000 |
65,000 |
|
|
|
|
|
Net Profit(Loss) |
101,047 |
12,004 |
56,782 |
(34,243) |
|
|
|
|
|
Net Profit(Loss) per share |
0.003 |
0.001 |
0.002 |
(0.002) |
Clement Forget,
President and CEO of Clemex Technologies Inc. declared: "We are
quite pleased with the results of this second Quarter of 2013.
Clemex had reasonable success in the manufacturing sector in the
USA where the automotive industry
continues to perform well since the beginning of the year. We have
also concluded important sales in the steel manufacturing
industries, a sector of activity that had declined in the last few
years. Finally, sales of our MicroHardness Testers, the Clemex
CMT.HD keep up at a steady rate, confirming that Clemex is
definitely offering one of the best instruments on worldwide market
for this field of application.
The CEO continued "Sales for this Quarter are in
line with our internal forecasts and take us back to
profitability. While we work on keeping expenses under
control, we invest more in marketing activities in view of the
introduction of the new line of instruments for Hematology which
should occur within the next six months. Concerning this matter,
Clemex along with its French partner RAL Diagnostics participated
at one of most important Medical instruments Trade show in the
world, Medica in Düsseldorf, Germany this past November where we introduced
our latest instrument, the HemaCyto 2L and the interest from the
show attendees was extremely positive. We have also just
exhibited the same instrument this week in Atlanta GA, USA, at the ASH (American Society
for Hematology) conference where we also had an excellent response
from the American Medical community. Our R & D team is working
very hard to fine tune the last details of the instruments while a
three month validation period will be required before the official
launching".
About Clemex Technologies, Inc.
Clemex Technologies Inc. develops, manufactures
and markets image analysis systems and software used by quality
control and research microscopy laboratories. Clemex' customer base
spans over many countries in America, Europe, Asia
and encompasses major Research and Development Centers, prestigious
Universities and large manufacturing industries in various fields
including healthcare, automotive, aerospace, raw materials
manufacturing, pharmaceuticals, mining and other sectors.
The CDNX has not reviewed and does not accept
responsibility for the adequacy and accuracy of this press
release.
SOURCE CLEMEX TECHNOLOGIES INC.